HOME Top Market Reports Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

Pen Needles Market by Type (Standard and Safety), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, and 12mm), Therapy (Insulin, Glucagon-like peptide, Growth Hormones) - Analysis & Global Forecast to 2019

By: marketsandmarkets.com
Publishing Date: October 2014
Report Code: MD 2851

Discount on Reports  

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global pen needlesmarket is segmented on the basis of type, needle length, therapy, and regions. Based on type,the pen needles market is categorized into standard and safety pen needles, while the market by needle length is segmented into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. Based on therapy, the market is categorized into insulin, Glucagon-like peptide (GLP), and growth hormones. The global pen needles market is expected to reach $2,105 million in 2019 from $1,283 million in 2014, growing at a CAGR of 10.4%.

Favorable reimbursement environment in North America & Europe, strong government support in the Pacific region, advantages of insulin pens over syringes and vials, technological advancements in pen needle technologies, andgrowing diabetic population are the significant factors driving this market. However, poor reimbursement structure in developing countries, severe shortage of Endocrinologists in the U.S., threats involved in reuse of pen needles, rising incidents of needlestick injuries (NSIs), and alternative drug delivery methods are the key factors that are restraining the growth of the market. Rising use of safety pen needles is likely to create opportunities for the market. However, minimizing the use of standard pen needles still remains a challenge for this market.

Some of the major players in the global pen needles market include Becton, Dickinson and Company (U.S.), Novo Nordisk (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

Scope of the Report

This research report categorizes the pen needles market into the following segments and subsegments:

By Type

  • Standard Pen Needles
  • Safety Pen Needles

By Needle Length

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

By Therapy

  • Insulin
  • Glucagon-like peptide
  • Growth Hormones

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia
  • Rest of the World (RoW)
    • Latin America
    • Pacific Countries
    • Middle East and Africa

Customization Option: List of Distributors: North and South America (Canada and Central/South America), Africa, Middle East, India, and South East Asia.

Table of Contents  
  
1 Introduction (Page No.- 15)

   1.1 Objectives Of The Study 
   1.2 Market Scope 
   1.3 Markets Covered 
   1.4 Stakeholders 
   1.5 Limitations 

2 Research Methodology (Page No.- 18)
   2.1 Secondary And Primary Research Methodology 
         2.1.1 Secondary Research 
         2.1.2 Key Data From Secondary Sources 
         2.1.3 Primary Research 
         2.1.4 Key Industry Insights 
                  2.1.4.1 Supply Side 
                  2.1.4.2 Demand Side  
         2.1.5 Key Data From Primary Sources  
         2.1.6 Key Insights From Primary Sources  
         2.1.7 Market Size Estimation Methodology  
         2.1.8 Market Forecast Methodology  
         2.1.9 Market Data Validation And Data Triangulation  
         2.1.10 Assumptions 

3 Executive Summary (Page No.- 27)

4 Premium Insights (Page No.- 31)
   4.1 Asia To Be The Fastest-Growing Region In The Pen Needles Market 
   4.2 Pen Needles Market, By Region And Therapy 
   4.3 Geographical Snapshot 
   4.4 Pen Needles Market, By Type 

5 Market Overview (Page No.- 34)
   5.1 Introduction 
   5.2 Market Segmentation 
   5.3 Market Dynamics 
         5.3.1 Drivers 
                  5.3.1.1 Favorable Reimbursement Environment In North America & Europe  
                  5.3.1.2 Strong Government Support In The Pacific  
                  5.3.1.3 Advantages Of Insulin Pens Over Syringes And Vials  
                  5.3.1.4 Technological Advancements  
                  5.3.1.5 Entry Of Companies Into The Pen Needles Market  
                  5.3.1.6 Growing Diabetic Population  
                  5.3.1.7 Awareness Campaigns/Conferences  
         5.3.2 Restraints  
                  5.3.2.1 Poor Reimbursement Structure In Developing Countries  
                  5.3.2.2 Needle Anxiety  
                  5.3.2.3 Severe Shortage Of Endocrinologists In The U.S.  
         5.3.3 Threats  
                  5.3.3.1 Risk Involved In Reusing Needles  
                  5.3.3.2 Alternative Drug Delivery Methods  
         5.3.4 Opportunities  
                  5.3.4.1 Safety Needles  
                  5.3.4.2 Glp-1 Analogs  
         5.3.5 Challenges  
                  5.3.5.1 Minimizing The Reuse Of Standard Pen Needle  
                  5.3.5.2 Conservatism Towards Adoption Of Pen Injectors  
         5.3.6 Trends  
                  5.3.6.1 Shorter & Higher-Gauge Needles  
                  5.3.6.2 Easy-To-Fit Needles 

6 Industry Insights (Page No.- 45)
   6.1 Porter’s Five Forces Analysis 
         6.1.1 Threat Of New Entrants  
         6.1.2 Supplier’s Bargaining Power  
         6.1.3 Buyer’s Bargaining Power  
         6.1.4 Segment Rivalry  
         6.1.5 Threat Of Substitutes  
   6.2 Competitive Intensity  
         6.2.1 Evaluation Parameters And Scores  
         6.2.2 Scoring Methodology  
         6.2.3 Competitive Intensity Score, By Company 
                   6.2.3.1 Competitive Intensity Score For Bd  
                   6.2.3.1 Competitive Intensity Score For Novo Nordisk  
                   6.2.3.2 Competitive Intensity Score For Ypsomed  
         6.2.4 Competitive Intensity Mapping Of Bd, Novo Nordisk, And Ypsomed  
         6.2.5 Comparison Of Evaluation Parameters,By Company  
                   6.2.5.1 Pricing  
                   6.2.5.2 Product Portfolio  
                   6.2.5.3 Product Launches/Technological Advancements  
                   6.2.5.4 Production Capacity (2013)  
                   6.2.5.5 Geographic Presence  
                   6.2.5.6 Promotional/Marketing Activities  
                   6.2.5.7 Sponsorship/Donations/Education/Awareness Campaigns  
                   6.2.5.8 M&A, Partnerships, Collaborations, Agreements, And Expansion  
                   6.2.5.9 Years Of Experience  
                   6.2.5.10 Certifications/Accreditations/Awards  
   6.3 Empirical Assessment Of Growth Strategies 
         6.3.1 Route To Strategic Growth: Organic And Inorganic Growth Strategies 
         6.3.2 Organic Growth Strategies 
         6.3.3 Inorganic Growth Strategies 

7 Pen Needles Market, By Type (Page No.- 67)
   7.1 Introduction 
   7.2 Standard Pen Needles 
   7.3 Safety Pen Needles 

8 Pen Needles Market, By Length (Page No.- 80)
   8.1 Introduction 

9 Pen Needles Market, By Therapy (Page No.- 85)
   9.1 Introduction 
   9.2 Insulin 
   9.3 Glucagon-Like Peptide-1 (Glp-1) 
   9.4 Growth Hormones 

10 Pen Needles Market, By Geography (Page No.- 90)
     10.1 Introduction 
     10.2 North America 
             10.2.1 U.S. 
                         10.2.1.1 Growing Diabetes Prevalence Coupled With Reimbursement For Pen Needle To Boost Market  
                         10.2.1.2 Federal Initiatives To Create Awareness About Injection Techniques To Stimulate U.S. Market  
                         10.2.1.3 Increasing Activities Of Leading Players To Penetrate The U.S. Market To Push The Sales In The Region  
                         10.2.1.4 Improved Pen Needle Technologies To Eliminate Needlestick Injuries To Fuel Market Growth  
                         10.2.1.5 Low Penetration Of Pen Injectors In U.S. As Compared To Europe  
             10.2.2 Canada 
                        10.2.2.1 High Diabetes Prevalence And Reimbursement For Pen Needle To Boost Market  
                        10.2.2.2 Government Support In Alberta To Increase Usage Of Pen Needle In The Region  
     10.3 Europe
             10.3.1 Germany 
                         10.3.1.1 Regulatory Framework To Minimize Needlestick Injuries & Boost Use Of Safety-Engineered Devices  
                         10.3.1.2 High Diabetes Prevalence And Reimbursement For Pen Needle To Accelerate German Market  
             10.3.2 U.K.  
                         10.3.2.1 Activities To Pool Funds For Diabetes Care & Research To Stimulate Use Of Needles  
             10.3.3 France  
                         10.3.3.1 Conferences And Exhibitions To Increase Exposure For Pen Needle Players In French Market  
                         10.3.3.2 Higher Insurance Coverage, Increase In Aging Population And Affordability Driving Market In France  
             10.3.4 Italy  
                         10.3.4.1 Wide Regional Variations In Terms Of Benefits And Coverage To Drive Slow Growth In Italy  
                         10.3.4.2 Awareness Campaigns For Diabetes In Italy To Propel The Market Growth  
             10.3.5 Spain 
                         10.3.5.1 Spain Is Amongst The Top 10 Countries With Highest Expenditure On Diabetes  
                         10.3.5.2 Spain Is Highly Active In Terms Of Exports Of Injectable Drug Delivery Devices  
             10.3.6 Rest Of Europe 
                         10.3.6.1 High Diabetes Prevalence In Russia, Turkey, Poland, Romania, And Ukraine To Propel The Market For Pen Needle  
     10.4 Asia 
             10.4.1 Japan 
                        10.4.1.1 High Adoption Of Insulin Pens And Approval Of Injectable Insulin To Fuel Market  
             10.4.2 China  
                        10.4.2.1 Growing Presence Of Global Players In China To Boost The Market  
                        10.4.2.2 High Diabetes Incidence And Adoption Of Insulin Pens To Stimulate The Market In China  
                        10.4.2.3 Low Penetration Of Insulin Pens, High Re-Usage Rate & Lack Of Reimbursement To Limit Market Growth  
             10.4.3 India  
                        10.4.3.1 Growing Presence Of Global Players In India To Propel The Market  
                        10.4.3.2 Rising Diabetes Incidence To Stimulate The Market In India  
             10.4.4 Rest Of Asia 
                         10.4.4.1 Vietnam A Potential Market For Pen Needle  
                         10.4.4.2 Singapore & Malaysia Likely To Showcase Increase In Adoption Of Market  
     10.5 Rest Of The World (RoW) 
              10.5.1 Latin America  
              10.5.2 Pacific Countries  
              10.5.3 Middle East & Africa  
  
11 Competitive Landscape (Page No.- 126)
     11.1 Overview 
     11.2 Market Share Analysis
             11.2.1 Introduction 
                         11.2.1.1 Becton, Dickinson And Company (U.S.)  
                         11.2.1.2 Novo Nordisk A/S (Denmark)  
                         11.2.1.3 Ypsomed Holding Ag (Switzerland)  
                         11.2.1.4 Others  
     11.3 Competitive Situation And Trends 
              11.3.1 Expansions  
              11.3.2 New Product Launches  
              11.3.3 Acquisitions  
              11.3.4 Others 

12 Company Profiles (Page No.- 138)
(Overview, Financials, Products & Services, Strategy, & Developments)*  
     12.1 Becton, Dickinson And Company 
     12.2 Novo Nordisk A/S 
     12.3 Ypsomed Holding Ag 
     12.4 Allison Medical, Inc. 
     12.5 Artsana S.P.A. 
     12.6 B. Braun Melsungen 
     12.7 Htl-Strefa S.A. 
     12.8 Owen Mumford, Ltd. 
     12.9 Terumo Corporation 
     12.10 Ultimed, Inc. 
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.  

13 Appendix (Page No.- 163)

     13.1 Discussion Guide
     13.2 Introducing Rt: Real-Time Market Intelligence
     13.3 Available Customizations
     13.4 Related Reports 
   
List of Tables (104 Tables)
     
Table 1 Emergence Of Several Local Pen Needle Manufacturers And Suppliers Is Observed Worldwide 
Table 2 Favorable Reimbursement Environment In North America & Europe Propelling The Growth Of Market 
Table 3 Poor Reimbursement Structure In Developing Countries Is Restraining The Growth Of Market 
Table 4 Risk Involved In Reuse Of Pen Needle A Major Threat To Pen Needles Market 
Table 5 Safety Needles Provide Greatest Potential For Pen Needles Market 
Table 6 Minimizing Reuse Of Standard Pen Needle A Major Challenge 
Table 7 Growing Trend Of Adoption Of Needles With Shorter Lengths & Higher Gauges 
Table 8 Evaluation Parameters And Scores 
Table 9 Competitive Intensity For Bd 
Table 10 Competitive Intensity For Novo Nordisk 
Table 11 Competitive Intensity For Ypsomed 
Table 12 Market Size, By Type, 2012–2019 ($Million) 
Table 13 Market Size, By Type, 2012–2019 (Million Units) 
Table 14 Standard Pen Needles Market Size, By Region, 2012–2019 ($Million) 
Table 15 Standard Pen Needles Market Size, By Region, 2012–2019 (Million Units) 
Table 16 North America: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 72 
Table 17 North America: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 73 
Table 18 Europe: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 73 
Table 19 Europe: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 74 
Table 20 Asia: Standard Pen Needles Market Size, By Country, 2012–2019 ($Million) 74 
Table 21 Asia: Standard Pen Needles Market Size, By Country, 2012–2019 (Million Units) 74 
Table 22 RoW: Standard Pen Needles Market Size, By Region, 2012–2019 ($Million) 75 
Table 23 RoW: Standard Pen Needles Market Size, By Region, 2012–2019 (Million Units) 75 
Table 24 Safety Pen Needles Market Size, By Region, 2012–2019 ($Million) 
Table 25 Safety Pen Needles Market Size, By Region, 2012–2019 (Million Units) 
Table 26 North America: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million) 77 
Table 27 North America: Safety Pen Needles Market Size, By Country, 2012–2019 (Million Units) 77 
Table 28 Europe: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million) 77 
Table 29 Europe: Safety Pen Needles Market Size, By Country, 2012–2019 (Thousand Units) 78 
Table 30 Asia: Safety Pen Needles Market Size, By Country, 2012–2019 ($Million)
Table 31 Asia: Safety Pen Needles Market Size, By Country, 2012–2019 (Million Units) 78 
Table 32 RoW: Safety Pen Needles Market Size, By Region, 2012–2019 ($Million) 
Table 33 RoW: Safety Pen Needles Market Size, By Country, 2012–2019 (Thousand Units) 79 
Table 34 Pen Needles Market Size, By Length, 2012–2019 ($Million) 
Table 35 North America: Market Size, By Length, 2012–2019 ($Million) 82 
Table 36 Europe: Market Size, By Length, 2012–2019 ($Million) 
Table 37 Asia: Market Size, By Length, 2012–2019 ($Million) 
Table 38 RoW: Market Size, By Length, 2012–2019 ($Million) 
Table 39 Pen Needles Market Size, By Therapy, 2012–2019 ($Million) 
Table 40 Insulin Market Size, By Region, 2012–2019 ($Million) 
Table 41 Glp-1 Market Size, By Region, 2012–2019 ($Million) 
Table 42 Growth Hormones Market Size, By Region, 2012–2019 ($Million) 
Table 43 Pen Needles Market Size, By Region, 2012–2019 ($Million) 
Table 44 Pen Needles Market Size, By Region, 2012–2019 (Million Units) 
Table 45 North America: Market Size, By Type, 2012–2019 ($Million) 
Table 46 North America: Market Size, By Type, 2012–2019 (Million Units) 
Table 47 North America: Market Size, By Country, 2012–2019 ($Million) 94 
Table 48 North America: Market Size, By Country, 2012–2019 (Million Units) 94 
Table 49 North America: Market Size, By Therapy, 2012–2019 ($Million) 95 
Table 50 Estimated Cost Savings From The Use Of Safety-Engineered Devices In The U.S. 
Table 51 U.S.: Market Size, By Type, 2012–2019 ($Million) 
Table 52 U.S.: Market Size, By Type, 2012–2019 (Million Units) 
Table 53 Canada: Market Size, By Type, 2012–2019 ($Million) 
Table 54 Canada: Market Size, By Type, 2012–2019 (Million Units) 
Table 55 Europe: Market Size, By Type, 2012–2019 ($Million) 
Table 56 Europe: Market Size, By Type, 2012–2019 (Million Units) 
Table 57 Europe: Market Size, By Country, 2012–2019 ($Million) 
Table 58 Europe: Market Size, By Country, 2012–2019 (Million Units) 
Table 59 Europe: Market Size, By Therapy, 2012–2019 ($Million) 
Table 60 Estimated Annual Number Of Infection Caused By Nsis In German Hospitals 
Table 61 Germany: Market Size, By Type, 2012–2019 ($Million) 
Table 62 Germany: Market Size, By Type, 2012–2019 (Million Units) 
Table 63 Highlights Of Diabetes U.K. Activities, 2013 
Table 64 U.K.: Market Size, By Type, 2012–2019 ($Million) 
Table 65 U.K.: Market Size, By Type, 2012–2019 (Million Units) 
Table 66 France: Market Size, By Type, 2012–2019 ($Million) 
Table 67 France: Market Size, By Type, 2012–2019 (Million Units) 
Table 68 Campaign Highlights: 
Table 69 Italy: Market Size, By Type, 2012–2019 ($Million) 
Table 70 Italy: Market Size, By Type, 2012–2019 (Million Units) 
Table 71 Spain: Market Size, By Type, 2012–2019 ($Million) 
Table 72 Spain: Market Size, By Type, 2012–2019 (Million Units) 
Table 73 RoE: Market Size, By Type, 2012–2019 ($Million) 
Table 74 RoE: Market Size, By Type, 2012–2019 (Million Units) 
Table 75 Asia: Market Size, By Type, 2012–2019 ($Million) 
Table 76 Asia: Market Size, By Type, 2012–2019 (Million Units) 
Table 77 Asia: Market Size, By Country, 2012–2019 ($Million) 
Table 78 Asia: Market Size, By Country, 2012–2019 (Million Units) 
Table 79 Asia: Market Size, By Therapy, 2012–2019 ($Million) 
Table 80 Japan: Market Size, By Type, 2012–2019 ($Million) 
Table 81 Japan: Market Size, By Type, 2012–2019 (Million Units) 
Table 82 China: Market Size, By Type, 2012–2019 ($Million) 
Table 83 China: Market Size, By Type, 2012–2019 (Million Units) 
Table 84 India: Market Size, By Type, 2012–2019 ($Million) 
Table 85 India: Market Size, By Type, 2012–2019 (Million Units) 
Table 86 RoA: Market Size, By Type, 2012–2019 ($Million) 
Table 87 RoA: Market Size, By Type, 2012–2019 (Million Units) 
Table 88 RoW: Market Size, By Type, 2012–2019 ($Million) 
Table 89 RoW: Market Size, By Type, 2012–2019 (Million Units) 
Table 90 RoW: Market Size, By Country, 2012–2019 ($Million) 
Table 91 RoW: Market Size, By Country, 2012–2019 (Million Units) 
Table 92 RoW: Market Size, By Therapy, 2012–2019 ($Million) 
Table 93 Latin America: Market Size, By Type, 2012–2019 ($Million)
Table 94 Latin America: Market Size, By Type, 2012–2019 (Thousand Units) 124 
Table 95 Pacific Countries: Market Size, By Type, 2012–2019 ($Million) 124 
Table 96 Pacific Countries: Market Size, By Type, 2012–2019 (Thousand Units) 124 
Table 97 Middle East & Africa: Market Size, By Type, 2012–2019 ($Million) 125 
Table 98 Middle East & Africa: Market Size, By Type, 2012–2019 (Thousand Units) 125 
Table 99 Bd, 2013 Awards, Recognitions, And Affiliations 
Table 100 Ypsomed’s Statistics On Pipeline Of Insulin Pens As Of 2013 
Table 101 Expansions, 2011–2014 
Table 102 New Product Launches, 2011–2013 
Table 103 Acquisitions, 2011–2014 
Table 104 Others, 2011–2014 
  
List of Figures (62 Figures)  
  
Figure 1 Research Methodology Steps 
Figure 2 Sampling Frame: Primary Research 
Figure 3 Breakdown Of Primary Interviews: By Company Type, Designation, And Region 
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach 
Figure 5 Market Size Estimation Methodology: Top-Down Approach 
Figure 6 Market Forecast Methodology 
Figure 7 Data Triangulation Methodology 
Figure 8 Market Snapshot, 2014–2019 
Figure 9 Safety Needles Market To Witness Highest Cagr Of 13.4% In Forecast Period 
Figure 10 Market For 4mm Pen Needles To Witness Highest Growth From 2014 To 2019  
Figure 11 Market Share, 2014 
Figure 12 Market Overview 
Figure 13 Europe Dominates The Pen Needles Market In 2014 
Figure 14 Asia To Grow At The Fastest Rate During The Forecast Period 
Figure 15 Standard Pen Needles Account For The Highest Share Of The Market, By Type 
Figure 16 Market Segmentation 
Figure 17 Market Dynamics 
Figure 18 Top 10 Countries/Territories For Number Of People With Diabetes (20–79 Years), 2013 And 2035 38 
Figure 19 Porter’s Five Forces Analysis
Figure 20 Scoring Methodology 
Figure 21 Comparison Of Competitive Intensity Scores: Bd, Novo Nordisk, And Ypsomed 
Figure 22 Relative Positioning Of Companies Based On Competitive Intensity Score And Pen Needle Focus 
Figure 23 Safety Pen Needles By Bd And Standard Pen Needles By Novo Nordisk Are Premium-Priced 
Figure 24 Bd Has Robust Portfolio Of Both Standard And Safety Pen Needles 
Figure 25 Bd Has High Focus On Innovation In Its Pen Needles Business 
Figure 26 Bd Has Highest Production Capacity Of Pen Needles 
Figure 27 Bd And Novo Nordisk Have Strong Geographic Presence 
Figure 28 Bd And Novo Nordisk Showcase High Focus On Marketing And Promotional Activities 
Figure 29 Novo Nordisk Has High Focus On Diabetes Education And Awareness 
Figure 30 Novo Nordisk Aggressively Follows Partnerships, Collaborations, Agreements, And Expansions 
Figure 31 Novo Nordisk, A Pioneer In Pen Needles Is Most Experienced Firm In Pen Needles Market 
Figure 32 Bd, Novo Nordisk, And Ypsomed Equally Exhibit High Compliance With Industry Standards 
Figure 33 Organic And Inorganic Growth Strategies 
Figure 34 Organic Growth Strategies, By Key Players (2011–2014) 
Figure 35 Inorganic Growth Strategies, By Key Players (2011–2014) 
Figure 36 Standard Pen Needles To Command Larger Share Of The Market In 2014
Figure 37 Market For Safety Pen Needles To Grow At The Highest Cagr From 2014 To 2019 69 
Figure 38 Indicative List Of Key Players (Manufacturers/Marketers) In Global Market 
Figure 39 Indicative List Of Players (Manufacturers/Marketers) In Pen Needles Market In Specific Countries 
Figure 40 6mm Pen Needles Segment To Command The Largest Share Of Market In 2014 
Figure 41 Insulin Therapy Segment To Command Largest Share Of Market In 2014 
Figure 42 Europe To Command Largest Share Of The Global Market 
Figure 43 U.S. Will Be Fastest-Growing Segment Of North American Market 
Figure 44 Germany To Be The Fastest-Growing Country Of Pen Needles Market In Europe 
Figure 45 Diabetes U.K. Works To Improve Quality Of Life Of Diabetic Population 
Figure 46 In 2012, Russia Had The Highest Diabetes Cases Of 12.7 Million Cases In Europe 
Figure 47 China Is The Fastest Growing Pen Needles Market In Asia 
Figure 48 Row To Account For A 10.5% Share Of The Global Market In 2014 
Figure 49 Companies Adopted Expansions Key Growth Strategy In Last Three Years 
Figure 50 Market Share Analysis, By Key Player, 2013 
Figure 51 Battle For Market Share: Expansion Was The Key Strategy 
Figure 52 Diabetes Care Revenue Mix And Product Protfolio Comparison Of Top Three Players 
Figure 53 Company Snapshot 
Figure 54 Company Snapshot 
Figure 55 Company Snapshot 
Figure 56 Company Snapshot 
Figure 57 Company Snapshot 
Figure 58 Company Snapshot 
Figure 59 Company Snapshot 
Figure 60 Company Snapshot 
Figure 61 Company Snapshot 
Figure 62 Company Snapshot  

The pen needles market is highly competitive with a large number of players, including both big and small players, operating in this market. Needles are used by patients to deliver insulin daily to their body. Rise in the global diabetic population and the increasing need for safety injections have resulted in technological advancements in this field.

The global pen needles market is segmented on the basis oftype, needle length, therapy, and region. By type, the pen needles market is categorized into standard and safety needles. The standard pen needles segment is expected to account for the largest share of the market, by type. However, the safety needles segment is expected to grow at the fastest rate in themarket, by type.

On the basis of needle length, the market is divided into 4mm, 5mm, 6mm, 8mm, 10mm, and 12mm. Pen needles with 6mm length is expected to account for the largest share of the market, by needle length. However, the needles with 4mm length are expected to grow at the fastest rate in the market, by needle length.

The pen needles market, by therapy is segmented into insulin, Glucagon-like peptide (GLP), and growth hormones. Insulin therapy is the largest (2014) and fastest (2014-2019) growing market of the market, by therapy.

The key factors that are expected to spur the growth of this market arethe rising global diabetic population, favorable reimbursement scenario in North America and Europe, technological advancements, and awareness campaigns and conferences to improve diabetes care and adoption market. However, poor reimbursement structure in developing countries, rising incidents of needlestick injuries (NSIs), and threats involved in reuse of pen needles are hindering the market growth.

On the basis of region, this market is classified into North America, Europe, Asia, andRest of the World (RoW).

Global Pen Needles Market Size, by Region, 2014 – 2019

Pen Needles Market

Source: MarketsandMarkets Analysis

The global pen needles market is expected to reach $2,105 million in 2019 from $1,283 million in 2014, growing at a CAGR of 10.4%. The market is dominated by Europe, followed by North America, Asia, and Rest of the World (RoW). Asia is expected to reach leadership position in terms of the value by 2019.

Some of the major players in the global market include Becton, Dickinson and Company (U.S.), Novo Nordisk (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-Strefa S.A. (Poland), Terumo Corporation (Japan), Artsana S.p.a (Italy), Owen Mumford Ltd (U.K.), Allison Medical, Inc. (U.S.), and Ultimed, Inc. (U.S.).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports